Gemcitabine is a widely used drug in the treatment of diverse malignancies and its use has been approved by US Food Drug Administration. This associated with rare adverse event, Hemolytic Uremic Syndrome (HUS), characterized acute kidney injury, microangiopathic hemolytic anemia, thrombocytopenia. The purpose this report to draw attention an atypical manifestation severe unusual complication, d...